Format

Send to

Choose Destination
Clin Chem. 2019 Dec;65(12):1487-1492. doi: 10.1373/clinchem.2019.307306. Epub 2019 Nov 7.

Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL.

Author information

1
Department of Laboratory Medicine, Yale University, New Haven, CT.
2
Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; aremaley1@nhlbi.nih.gov.
3
Professor and Chief Physician, Department of Clinical Biochemistry, Herlev Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark.
4
Senior Medical Director, Medical Informatics, Quest Diagnostics, Secaucus, NJ.
5
Director, Center for Lipid Metabolomics, Divisions of Preventive and Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
6
Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX.
7
Department of Pathology, Texas Children's Hospital, Houston, TX.
8
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center